These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25074521)

  • 1. Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors.
    Almeida PV; Shahbazi MA; Mäkilä E; Kaasalainen M; Salonen J; Hirvonen J; Santos HA
    Nanoscale; 2014 Sep; 6(17):10377-87. PubMed ID: 25074521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrin-Modified Porous Silicon Nanoparticles for Efficient Sustained Drug Delivery and Proliferation Inhibition of Breast Cancer Cells.
    Correia A; Shahbazi MA; Mäkilä E; Almeida S; Salonen J; Hirvonen J; Santos HA
    ACS Appl Mater Interfaces; 2015 Oct; 7(41):23197-204. PubMed ID: 26440739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
    Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
    Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
    Yu M; Jambhrunkar S; Thorn P; Chen J; Gu W; Yu C
    Nanoscale; 2013 Jan; 5(1):178-83. PubMed ID: 23076766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering.
    Shahbazi MA; Almeida PV; Mäkilä EM; Kaasalainen MH; Salonen JJ; Hirvonen JT; Santos HA
    Biomaterials; 2014 Aug; 35(26):7488-500. PubMed ID: 24906344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration.
    Jeong JY; Hong EH; Lee SY; Lee JY; Song JH; Ko SH; Shim JS; Choe S; Kim DD; Ko HJ; Cho HJ
    Acta Biomater; 2017 Apr; 53():414-426. PubMed ID: 28216300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride.
    Tzur-Balter A; Gilert A; Massad-Ivanir N; Segal E
    Acta Biomater; 2013 Apr; 9(4):6208-17. PubMed ID: 23274152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
    Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
    Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells.
    Gary-Bobo M; Brevet D; Benkirane-Jessel N; Raehm L; Maillard P; Garcia M; Durand JO
    Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):256-60. PubMed ID: 22959805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer.
    Lin T; Yuan A; Zhao X; Lian H; Zhuang J; Chen W; Zhang Q; Liu G; Zhang S; Chen W; Cao W; Zhang C; Wu J; Hu Y; Guo H
    Acta Biomater; 2017 Apr; 53():427-438. PubMed ID: 28213097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor.
    Phua SZF; Yang G; Lim WQ; Verma A; Chen H; Thanabalu T; Zhao Y
    ACS Nano; 2019 Apr; 13(4):4742-4751. PubMed ID: 30964974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and cytotoxicity of docetaxel-loaded hyaluronic acid-grafted oily core nanocapsules in MDA-MB 231 cancer cells.
    Youm I; Agrahari V; Murowchick JB; Youan BB
    Pharm Res; 2014 Sep; 31(9):2439-52. PubMed ID: 24643931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azo modified hyaluronic acid based nanocapsules: CD44 targeted, UV-responsive decomposition and drug release in liver cancer cells.
    Chen Q; Li X; Xie Y; Hu W; Cheng Z; Zhong H; Zhu H
    Carbohydr Polym; 2021 Sep; 267():118152. PubMed ID: 34119127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronan-decorated polymer nanoparticles targeting the CD44 receptor for the combined photo/chemo-therapy of cancer.
    Maiolino S; Moret F; Conte C; Fraix A; Tirino P; Ungaro F; Sortino S; Reddi E; Quaglia F
    Nanoscale; 2015 Mar; 7(13):5643-53. PubMed ID: 25648974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells.
    Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A
    Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killing colon cancer cells through PCD pathways by a novel hyaluronic acid-modified shell-core nanoparticle loaded with RIP3 in combination with chloroquine.
    Hou X; Yang C; Zhang L; Hu T; Sun D; Cao H; Yang F; Guo G; Gong C; Zhang X; Tong A; Li R; Zheng Y
    Biomaterials; 2017 Apr; 124():195-210. PubMed ID: 28199887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.